Product
SPN-817
1 clinical trial
2 indications
Indication
EpilepsyIndication
SeizureClinical trial
RENAISSANCE Study: A Phase 2, Multicenter, Open Label Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant EpilepsyStatus: Recruiting, Estimated PCD: 2024-10-01